FIELD: pharmaceutics.
SUBSTANCE: present invention relates to novel compounds of formula (I), as well as to their pharmaceutically acceptable salts possessing activity of HSL inhibitors, to pharmaceutical composition, method of inhibiting of enzyme HSL lipase, as well as to use of disclosed compounds for preparing a drug. Values R1, R2, R3, Ca and Cb are given in the claim.
EFFECT: invention discloses spiro-condensed cyclohexane derivatives as inhibitors of HSL, effective for diabetes treatment.
24 cl, 377 ex
Title | Year | Author | Number |
---|---|---|---|
NEW AZACYCLIC COMPOUNDS | 2011 |
|
RU2603263C2 |
2,8-DIAZASPIRO[4,5]DECAN-1-ONE DERIVATIVES, USEFUL AS INHIBITORS OF HORMONE-SENSITIVE LIPASE (HSL) | 2011 |
|
RU2606513C2 |
AZACYCLIC SPIRO-COMPOUNDS | 2010 |
|
RU2550495C2 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
PHENYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS | 2016 |
|
RU2728823C1 |
2-AMINOBENZOTHIAZOLYLUREAS AS ADENOSINE MODULATORS | 2002 |
|
RU2311905C2 |
COMPOUNDS AND COMPOSITIONS FOR SUPPRESSING SHP2 ACTIVITY | 2017 |
|
RU2744988C2 |
AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | 2011 |
|
RU2567395C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
Authors
Dates
2017-01-10—Published
2010-10-12—Filed